Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Diabetes technology news.

Walczak IM.

Diabetes Technol Ther. 2003;5(5):891-920. No abstract available.

PMID:
14633360
2.

Diabetes technology news. Calcium antagonists aid high blood pressure control.

Walczak IM.

Diabetes Technol Ther. 2003;5(3):510-1. No abstract available.

PMID:
12838935
3.

Diabetes technology news. FDA approves CYPHER Stent.

Walczak IM.

Diabetes Technol Ther. 2003;5(3):509-10. No abstract available.

PMID:
12838934
4.

Diabetes technology news. International Consortium completes human genome sequencing.

Walczak IM.

Diabetes Technol Ther. 2003;5(3):493-4. No abstract available.

PMID:
12828837
5.

Researchers expand & preserve stem cells for cellular therapies.

Walczak IM.

Diabetes Technol Ther. 2003;5(1):131. No abstract available.

PMID:
12733539
6.

FDA clears home glycated hemoglobin test for diabetics.

Walczak IM.

Diabetes Technol Ther. 2003;5(1):124. No abstract available.

PMID:
12733538
7.

Studies show Lantus to be effective, safe and flexible in the treatment of type 1 diabetes.

Walczak IM.

Diabetes Technol Ther. 2002;4(5):744-5. No abstract available.

PMID:
12458569
8.

Endovasc establishes orphan drug test.

Walczak IM.

Diabetes Technol Ther. 2002;4(5):740-1. No abstract available.

PMID:
12458568
9.

Lilly and Amylin to collaborate on potential breakthrough diabetes treatment.

Walczak IM.

Diabetes Technol Ther. 2002;4(5):738-9. No abstract available.

PMID:
12458567
10.

Lantus reduces blood glucose levels, less hypoglycemia in treatment of type 2 diabetes.

Walczak IM.

Diabetes Technol Ther. 2002;4(5):735-6. No abstract available.

PMID:
12458566
11.

Theratechnologies expands peptide portfolio in endocrinology.

Walczak IM.

Diabetes Technol Ther. 2002;4(5):734. No abstract available.

PMID:
12458565
12.

Diabetes technology news.

Walczak IM.

Diabetes Technol Ther. 2001 Winter;3(4):665-98. No abstract available.

PMID:
11911182
13.

House panel takes up Medicare drug bill.

Walczak IM.

Diabetes Technol Ther. 2000 Autumn;2(3):491-2. No abstract available.

PMID:
11467354
14.

FDA panel vetoes OTC version of cholesterol drug.

Walczak IM.

Diabetes Technol Ther. 2000 Autumn;2(3):484. No abstract available.

PMID:
11467353
15.

FDA advisers vote against OTC Pravachol.

Walczak IM.

Diabetes Technol Ther. 2000 Autumn;2(3):483-4. No abstract available.

PMID:
11467352
16.

Fiber optic evanescent wave immunosensors for medical diagnostics.

Bluestein BI, Walczak IM, Chen SY.

Trends Biotechnol. 1990 Jun;8(6):161-8. Review.

PMID:
1366619
17.

[Evaluation of students in the pediatric department].

Walczak I.

Pieleg Polozna. 1984;(11-12):17-8. Polish. No abstract available.

PMID:
6570545
18.

Separation of leukemic cells into proliferative and quiescent subpopulations by centrifugal elutriation.

Preisler HD, Walczak I, Renick J, Rustum YM.

Cancer Res. 1977 Nov;37(11):3876-80.

19.
20.

Absorption of acetate, pyruvate and certain Krebs cycle intermediates by Fasciola hepatica.

Isseroff H, Walczak IM.

Comp Biochem Physiol B. 1971 Aug 15;39(4):1017-21. No abstract available.

PMID:
5132533

Supplemental Content

Loading ...
Support Center